5M BIOMED, LLC

Johns Creek, GA · Medtech · Private

Blood-based multiplexed Alzheimer's disease biomarker detection platform using ultramagnetic iron oxide nanorods with anti-biofouling polymer coating

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Johns Creek, GA
Total capital
$3.4M
Federal grants
$3.4M
7 awards · 2020–2026
Rank in peer group#277 of 538
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
6 pending

Capital timeline

2020202120222023202420252026FEDERAL ↑EQUITY ↓Cumulative $3.4M$320K$400K$400K$306K$889K$811K
2020202220242026FEDERAL ↑EQUITY ↓Cumulative $3.4M$400K$400K$889K$811K

Latest events

  • Federal grantHealth and Human S · Phase II · Development of "Imagnostix": A Liquid Biopsy System for Alzheimer's Disease$811K
  • Federal grantHealth and Human S · Phase II · Development of "Imagnostix": A Liquid Biopsy System for Alzheimer's Disease$889K
  • Federal grantHealth and Human S · Phase I · Multi-functional magnetic nanorods for constructing theranostic extracellular vesicles for treating myocardial infarction$306K
  • Federal grantHealth and Human S · Phase I · Highly Sensitive and Robust Blood Test Platform for Screening and Early Detection of Alzheimer's Disease$400K
  • Federal grantHealth and Human S · Phase I · Small Intestine Targeted Fast Acting Oral Insulin Formulation$300K
  • Federal grantHealth and Human S · Phase I · A New Class of Magnetic Nanoparticles for Glioma Targeted Drug Delivery$400K
  • Federal grantHealth and Human S · Phase I · Serum Detection of Medulloblastoma Metastasis$320K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Linked publications#34 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 6
  • PendingPolymer Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofUSPTOApplication 18521615
  • PendingOligosaccharide And/or Polysaccharide Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofUSPTOApplication 19481185
  • PendingPolymer Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofUSPTOApplication PCTUS2023081349
Show all 6 patent records
  • Polymer Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofNov 7, 2024 · Application 18521615Pending
  • Oligosaccharide And/or Polysaccharide Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofApplication 19481185Pending
  • Polymer Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofApplication PCTUS2023081349Pending
  • Oligosaccharide And/or Polysaccharide Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofApplication PCTUS2023079303Pending
  • Oligosaccharide And/or Polysaccharide Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofApplication 63500396Pending
  • Polymer Coated Iron Oxide Nanorods And Methods Of Making And Use ThereofApplication 63500389Pending

Recent research by its founders

  • Associations of plasma proteomic and polygenic profiling with incident psoriasis risk: a prospective cohort study20260 cites
  • Robust decoding for MI-EEG: a hybrid transformer network using multi-perspective collaborative attention and dynamic hyperbolic tangent20260 cites
  • Machine Learning Model for Predicting Biliary Complications After Liver Transplantation20255 cites

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .